Chiara Ambrogio

She has worked extensively in the area of tumor initiation processes, translational cancer research and pre-clinical evaluation of novel drugs for the treatment of lung cancer. After training with Mariano Barbacid at the CNIO (2009-2016) and Pasi Janne at the Dana Farber Cancer Institute (2016-2019), she established her Molecular Oncology Laboratory at the Molecular Biotechnology Center (MBC)-Department of Biotechnology and Health Sciences in 2020 (https://ambrogiolab.com) thanks to prestigious grants from the ERC and the Harvard Armenise Foundation.